Ethyl 2-amino-2-iminoacetate hydrochloride, 95.0%, 250mg

2-(1H-Indol-3-yl)-4-oxo-4-phenyl-butyric acid, 25mg

Propylene glycol monopropyl ether, min 99%, for synthesis, 1L, plastic packaging.

ETHYL 4-(1,3-DIOXOISOINDOLIN-2-YL)-3-OXOBUTANOATE, 95.0%, 1g

Ethyl 2-(benzo[d][1,3]dioxol-5-yl)thiazole-4-carboxylate, 95.0%, 250mg

4-Bromophenyl-(4-fluorobenzyl)ether, 97.0%, 2g

3-Bromo-5-chloronitrobenzene, 95.0%, 5g

4-chloro-3,5-difluoropyridine hydrochloride, 1g

Diethyl 2-(4-chlorophenyl)malonate, 95.0%, 10g

2,6-Di-tert-butyl-4-methylphenol, 95.0%, 1kg

2-Fluorocyclobutane-1-carboxylic acid, 98%, 10g

Spiro[indene-1,4'-piperidine], 95.0%, 1g

1-(6-Bromopyridin-3-yl)-N,N-dimethylmethanamine, 98%, 5g